Products / Onchology y Oncohematology

Omilipis

Carboplatin 150-450 mg

Carboplatin is indicated for the treatment of the advanced epithelial ovarian cancer and small cell lung cancer, associated to other chemotherapy treatments.

Therapeutic Action

Antineoplastic

Presentations

1 lyophilized vial

Omilipis Carboplatin 150-450 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use